Our data show that the IgM‐IVIg did not prevent bacterial infection, but instead enhanced its clearance with a significant reduction in lung bacterial burden in IgM‐IVIg‐treated animals not apparent until 5‐day post‐MCAO. The gene discussed is CD40LG; the disease is bacterial infectious disease.